Serum adiponectin and resistin levels in patients with obsessive compulsive disorder
dc.contributor.author | Ari, Mustafa | |
dc.contributor.author | Ozturk, Oktay Hasan | |
dc.contributor.author | Bez, Yasin | |
dc.contributor.author | Arica, Secil | |
dc.contributor.author | Can, Yesim | |
dc.contributor.author | Erduran, Dudu | |
dc.date.accessioned | 2024-09-18T20:52:49Z | |
dc.date.available | 2024-09-18T20:52:49Z | |
dc.date.issued | 2012 | |
dc.department | Hatay Mustafa Kemal Üniversitesi | en_US |
dc.description.abstract | We aimed to investigate the changes in serum adiponectin and resistin levels in patients with obsessive compulsive disorder and control groups. The serum adiponectin and resistin levels of 29 patients (16 females, 13 males) with obsessive compulsive disorder and weight, age and sex-matched 31 healthy controls (17 females, 14 males) were determined. Yale-Brown Obsessive Compulsive Scale (Y-BOCS) was applied to all groups. ELISA method was used to measure adiponectin and resistin levels. The mean adiponectin level was 11.92 +/- 2.04 ng/ml and resistin level was 13.23 +/- 2.78 ng/ml in obsessive compulsive disorder group, while it was 18.81 +/- 5.24 ng/ml and 8.17 +/- 2.53 ng/ml in control group. Changes in plasma adiponectin and resistin levels in obsessive compulsive disorder may have implications about possible cardiovascular and metabolic abnormalities seen in obsessive compulsive patients. (C) 2011 Published by Elsevier B.V. | en_US |
dc.description.sponsorship | Mustafa Kemal University Scientific Research Unit | en_US |
dc.description.sponsorship | Mustafa Kemal University Scientific Research Unit supported us financially to obtain resistin and adiponectin elisa kits. | en_US |
dc.identifier.doi | 10.1016/j.jad.2011.07.029 | |
dc.identifier.endpage | 982 | en_US |
dc.identifier.issn | 0165-0327 | |
dc.identifier.issn | 1573-2517 | |
dc.identifier.issue | 3 | en_US |
dc.identifier.pmid | 22119090 | en_US |
dc.identifier.scopus | 2-s2.0-84857356222 | en_US |
dc.identifier.scopusquality | Q1 | en_US |
dc.identifier.startpage | 979 | en_US |
dc.identifier.uri | https://doi.org/10.1016/j.jad.2011.07.029 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12483/11427 | |
dc.identifier.volume | 136 | en_US |
dc.identifier.wos | WOS:000301996000104 | en_US |
dc.identifier.wosquality | Q1 | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.indekslendigikaynak | Scopus | en_US |
dc.indekslendigikaynak | PubMed | en_US |
dc.language.iso | en | en_US |
dc.publisher | Elsevier | en_US |
dc.relation.ispartof | Journal of Affective Disorders | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Obsessive compulsive disorder | en_US |
dc.subject | Anxiety | en_US |
dc.subject | Adiponectin | en_US |
dc.subject | Resistin | en_US |
dc.title | Serum adiponectin and resistin levels in patients with obsessive compulsive disorder | en_US |
dc.type | Article | en_US |
Dosyalar
Orijinal paket
1 - 1 / 1